


Presbyterian/St. Luke’s Medical Center (P/SL) has spent $30 million to buy, expand and open new cancer-care centers since the start of October, as hospital officials hope the investment will position it as a market leader in treating the disease. Read more: P/SL expands cancer-care offerings in growing field | Denver Business Journal
The Comprehensive Cancer Center at P/SL is approved by the American College of Surgeons (ACoS) Commission on Cancer as a "Community Hospital Comprehensive Cancer Program." P/SL undergoes a rigorous survey process to ensure that ACoS program requirements are met.
Our Comprehensive Cancer Center treats patients suffering from virtually any type and stage of cancer, from hematologic malignancies to soft tissue malignancies to brain tumors. When you consider there are more than 100 types of cancer, it's good to know P/SL has physicians in every cancer specialty.
Our Comprehensive Cancer Center offers advanced diagnostic technologies to help patients obtain accurate information with greater ease, safety, and efficiency.
The P/SL Blood & Marrow Transplant (BMT) Center achieved F.A.C.T. accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). This endoresment recognizes that our BMT program has met FACT's standards for providing quality medical and laboratory practice in blood and marrow transplantation.Our BMT program is one of a limited number of programs nationwide to receive this honor.
Because kids with cancer have special needs, we specialize in their care at Rocky Mountain Hospital for Children at P/SL (RMHC at P/SL). RMHC at P/SL has pediatric cancer specialists on the P/SL campus and the new Rocky Mountain Hospital for Children at P/SL facility located on 19th and High Streets.